Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Ouali, M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(10)
+
-
Availability
Open access
(4)
+
-
Metadata Only
(6)
+
-
Creation Date
2012
(4)
+
-
2014
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(10)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(10)
+
-
Topic
soft tissue sarcoma
(2)
+
-
Author
Ouali, M.
(10)
+
-
Blay, J.Y.
(8)
+
-
Hohenberger, P.
(8)
+
-
Cesne, A. le
(7)
+
-
Gelderblom, H.
(6)
+
-
Hogendoorn, P.C.W.
(6)
+
-
Marreaud, S.
(6)
+
-
Graaf, W.T.A. van der
(5)
+
-
Casali, P.G.
(4)
+
-
Aglietta, M.
(3)
+
-
Araki, N.
(3)
+
-
Beppu, Y.
(3)
+
-
Bonvalot, S.
(3)
+
-
Chawla, S.P.
(3)
+
-
Glabbeke, M. van
(3)
+
-
Judson, I.R.
(3)
+
-
Rutkowski, P.
(3)
+
-
Sleijfer, S.
(3)
+
-
Staddon, A.P.
(3)
+
-
Verweij, J.
(3)
+
-
Coevorden, F. van
(2)
+
-
Demetri, G.D.
(2)
+
-
Dewji, M.
(2)
+
-
Gronchi, A.
(2)
+
-
Hodge, R.
(2)
+
-
Hoekstra, H.J.
(2)
+
-
Kim, D.W.
(2)
+
-
Krarup-Hansen, A.
(2)
+
-
Leahy, M.
(2)
+
-
Litiere, S.
(2)
+
-
Nguyen, B.B.
(2)
+
-
Ray-Coquard, I.
(2)
+
-
Schoffski, P.
(2)
+
-
Show more
Language
en
(10)
+
-
Search results
(1 - 10 of 10)
show grid
show list
save search
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogeneti
Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis-an EORTC STBSG and ROG study (EORTC 62991-22998)
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
Global differences in chemotherapeutic regimens of soft tissue sarcoma (STS): Results of PALETTE, an EORTC 62072/GSK VEG110727 global network phase III trial of pazopanib versus placebo
PALETTE: Final overall survival (OS) data and predictive factors for OS of EORTC 62072/GSK VEG110727, a randomized double-blind phase III trial of pazopanib versus placebo in advanced soft tissue sarcoma (STS) patients
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas An exploratory, retrospective analysis on large series from the European Organization for Research and Tre